Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review

BACKGROUND: Health-related quality of life (HRQoL) is recognized as a component endpoint for cancer therapy approvals. The aim of this review was to evaluate the methodology of HRQoL analysis and reporting in phase III clinical trials of first-line chemotherapy in advanced non-small cell lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiteni, Frédéric, Anota, Amélie, Westeel, Virginie, Bonnetain, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758022/
https://www.ncbi.nlm.nih.gov/pubmed/26892541
http://dx.doi.org/10.1186/s12885-016-2152-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758022/
https://www.ncbi.nlm.nih.gov/pubmed/26892541
http://dx.doi.org/10.1186/s12885-016-2152-1

Ejemplares similares